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A large Dutch hospital is currently implementing
a system for the Electronic Prescription of
Medication (EPM). Given the serious nature of
prescriptions, there is a need for strong
authentication. In order to fulfill this need, a set
of standards and a framework for authentication
is being created. In doing so, the hospital has run
into implementation issues concerning the
authentication process. Prominent among these
issues are the legal ones. One of the problems
that arise is the lack of acceptance amongst
doctors and other professionals of electronic
signatures for electronic prescriptions. The article
will address the discrepancies between Dutch
law and practice, and will offer an insight to the
solutions found for the hospital involved.
Discrepancies between law and practice  
More and more Dutch hospitals are implementing a
system for electronic prescription of medication for
reasons of medication safety and efficiency. The
forthcoming Medication Dossier that should have been
implemented on 1 January 2006 with the purpose of
increasing safety concerning medication, plays an
important role in the implementation of new
prescription systems. Obtaining the electronic
authorization of the doctor should be taken into account
when designing such a system. However, it is not so
straightforward for a doctor to use an electronic
signature. If doctors do not accept this new electronic
system, implementation of an EPM could fail. If a doctor
does not give his authorization for the prescription from
the hospital pharmacy, then the medicine will not be
distributed. In practice, this does not mean that
medication is not distributed by the pharmacy if a
prescription has not been authorized. This article
discusses the discrepancies between law and practice
and tries to offer a solution to the authorization of
prescriptions and medication orders.
Electronic signatures
The Directive 1999/93/EC of the European Parliament
and of the Council of 13 December 1999 on a Community
framework for electronic signatures (OJ 19.1.2000
L13/12) is implemented in the Dutch Civil Code (BW),
the Telecommunications Act (Tw) and the Economic
Offences Act (WED).
Article 2(1) of the Directive and article 3:15a
paragraph 4 BW define the electronic signature as:
“data in electronic form which are attached to or
logically associated with other electronic data and
which serve as a method of authentication.” According
to article 3:15a paragraph 1 BW the electronic signature
has the same status as a manuscript signature if the
method used for authentication is sufficiently reliable
and taken the purpose of the signature and all other
circumstances into account. Besides the ‘regular’
electronic signature, the EU Directive provides for an
advanced electronic signature in article 2(2) that is
generally considered more secure. Article 3:15a
paragraph 2 BW sets six requirements which an
electronic signature must meet in order to be
considered as sufficiently reliable:
• it is uniquely linked to the signatory;
• it is capable of identifying the signatory;
• it is created using means that the signatory can
maintain under his sole control;
• it is linked to the data to which it relates in such a
manner that any subsequent change of the data is
detectable;
• it is based on a qualified certificate;
• it is generated by secure-signature-creation device. 
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The advanced electronic signature consists of a
unique public and private key that are inseparably
linked to each other. Such a public and private key
(capable of being deployed within a Public Key
Infrastructure) is based on symmetric keys; the private
key of the person in control of the digital signature and
the public key for those who are allowed to obtain
access to the data. A certification-service provider (in
practice commonly known as Trusted Third Party or TTP)
records who belongs to which key within the digital
certificate. Electronic signing is done with the private
key (usually a personal identification number). The
recipient of the data then uses the public key to verify
the message.1 Besides the distinction between regular
and advanced electronic signatures, the Directive also
draws a distinction between regular and qualified
certificates. A regular certificate is an electronic
confirmation that interconnects data to a certain person
for the purposes of verification of the signature and
confirms the identity of that person. A qualified
certificate is more secure. Among others, a qualified
certificate should contain the following information:
“an indication that the certificate is issued as a
qualified certificate, the identification of the
certification-service-provider and the State in which it
is established, an indication of the beginning and end
of the period of validity of the certificate, limitations
on the scope of use of the certificate, if applicable”.2
If all requirements are fulfilled, the electronic
signature can be regarded as legally equivalent to hand-
written signatures. This does not mean that if electronic
signatures do not meet the requirements, they cannot
be regarded as legally binding (article 3:15a paragraph
6 BW). It depends on any agreements there may be
between contracting parties, (such as the prescribing
doctor and the delivering hospital pharmacy), the
transaction and purposes of sending the data whether
the electronic signatures can be regarded as legally
binding. It is open for a judge to confirm the legal force
of the electronic signature. The following paragraph sets
out the rules for signing the prescription the distinction
between ‘regular’ and ‘special’ prescriptions. 
The electronic signature and the ‘regular’
prescription
In contrast to the relations between a family physician
and the city pharmacy where the term ‘prescription’ is
used, hospitals use the term ‘medication order’. The
Dutch Law does not mention such a term, but uses the
term ‘prescription’. If the sole distribution of medication
is meant, there is no difference between a prescription
and a medication order. The report “Distribution of
medication within healthcare institutions” summarises
the term as follows: ‘a medication order is an instruction
to a nurse with regard to the administration of
medication.’ 3 The medication order can also be used to
acquire medicines (not being general stock) that are
mentioned on the order. As a result, the medication
order becomes a prescription and the pharmacist
should handle the prescription accordingly. The only
difference, therefore, between a medication order and a
prescription, is that the latter contains an instruction to
the nurse on the administration of the drugs. The
medication order should therefore comply with the legal
rules on the distribution of prescription drugs.
According to article 5(2) of the Regulation on the
distribution of medication on prescription only
(Regeling U.R.-geneesmiddelen; further RURg), a
prescription (also that particular part of a medication
order) should meet the following requirements (on the
basis of paragraph 1 a pharmaceutical product should
only be distributed if a written request is received): the
request must be signed and contains the name, address
and capacity of the requester, and the name and
quantity of the pharmaceutical products.
The prescription must be authorized by the prescriber
(doctors, dentist and obstetricians). The authorization
must also contain a name and signature, whether or not
electronically. It must be clear and indisputable who
signed the prescription, which makes it obvious who is
responsible for the authorization. Without a signature,
the pharmacy cannot distribute the medication, and this
signature must be in place before the prescription is
send to the pharmacy.4 The meaning of article 5
paragraph 2 RURg clearly shows that permitting a
person other than the prescriber sign the prescription
is, in principle, not allowed. In view of the use of
electronic signatures, there is reason to refer to article
3:15a paragraph 5 BW, which defines the term signatory
as follows: ‘The signatory is a person who holds a
signature-creation device’. Even though this should not
lead to the conclusion that the person signing the
message is also the drawer of the message, the
signatory is the one that is identified as the sender of
1 Also: TK 2000–2001, 27 743, nr. 3 Explanatory
statement for the implementation of Directive
1999/93/EC (Dutch only).
2 Directive 1999/93/EC Annex I. and TK 2000–2001,
27 743, nr. 3 2 Explanatory statement for the
implementation of Directive 1999/93/EC, p. 3
(Dutch only).
3 Geneesmiddelendistributie binnen inrichtingen
voor gezondheidszorg. Rapport 30.
Leidschendam: Staatstoezicht op de
volksgezondheid. 1980, p. 14, 24-25, 28 
(Dutch Only).
4 Zie: I.H. van der Sijs, T.F.M. Hooghiemstra, ‘Hoe
het moet, hoe het mag en hoe het zou kunnen.
Juridische aspecten van elektronisch voorschrijven
in ziekenhuizen’, Pharmaceutisch weekblad, 17
september 2004, jaargang 139 nr. 38, p. 1224-1228
(Ducth Only).
THE ELECTRONIC PRESCRIPTION OF MEDICATION IN A NETHERLANDS HOSPITAL
57www.deaeslr.org DIGITAL EVIDENCE AND ELECTRONIC SIGNATURE LAW REVIEW
the message, and in this case, as the rightful requester
of the prescription. The signatory does not have to sign
his request for medication distribution solely with his
signature, but also with his name and capacity. It would
therefore not be logical to assume that somebody other
than the requester (such as a colleague) can sign the
prescription, even if this other person has the
competency to do so. In the Electronic Prescription of
Medication system, there is a possibility to authorize
prescriptions from other prescribers as long as the
signatory has the authority. As a result, the signature
will no longer correspond with the initial prescriber of
the medication.
Electronic signatures and ‘special’
prescriptions 
A prescription or medication order containing multiple
medicines cannot contain medicines listed under the
Opium Act.5 Like the RURg, the Decree on the
prescription and ordering of products covered by the
Opium Law6 requires in article 1(1)(1) that a prescription
is required to contain the name, address and capacity of
the requestor. What deviates from the RURg is the
second paragraph. According to article 1(2) of the
Decree, the prescription should be written in ink and
should be accompanied by a full signature.
The first question leads to the conclusion that a
prescription, as mentioned in the Opium Act, cannot be
produced electronically, because the article refers to a
prescription written in ink. In practice, such
prescriptions are not hand written but electronically
produced. Producing a prescription in ink can also mean
that the prescription is printed on an inkjet printer,
which automatically fulfils the requirements. There is no
requirement that the prescription should be written by
hand. Since the reasoning behind the Opium Act is that
medicines listed in this Act can only be distributed
under stringent conditions, it does not follow that in
view of safety of prescriptions, that electronic
production is prohibited. In view of medication safety,
this is favourable; a handwritten signature no longer
needs deciphering, and there is no doubt about the
requested pharmaceutical and quantity. In hospitals
that intend to implement and have implemented the
EPM, prescriptions based on the Opium Law are
electronically authorized. Such an electronic signature is
not contrary to the law, even though the Opium Act is
not equipped for such signatures yet. The EU Directive
regards electronic signatures with a qualified certificate
as legally equivalent to hand-written signatures, so
adjustment of the Opium Law to allow electronic
prescriptions and authorization is recommended in view
of the far-reaching development of electronic appliances
in healthcare.
The second question is whether the signature
required by the Opium Law on the  prescription
necessarily needs to be a full signature. Since the RURg
does not mention the requirement for a full signature
but just signature, signing the prescription can also be
done with initials. Even though the law does not
mention this possibility, it is possible to derive from
initials, the name of the person who purported to sign
the message. This might be a reason to accept initials
as a signature. In view of the electronic signature, this is
not unusual; there is no distinction between an
electronic initial and an electronic signature. It is either
signed or not signed.
Hospital practice
Prescribing medication listed under the RURg or the
Opium Act is a daily practice in a hospital. Since
medicines are increasingly prescribed electronically, it is
important to pay attention to the way prescriptions are
authorized. The hospital’s Electronic Prescription of
Medication system uses a username and password as
the current means of authorization. Article 2(3) of the
EU Directive, in conjunction with article 3:15a paragraph
5 BW, indicates the meaning of the term signatory: ‘a
person who holds a signature-creation device and acts
either on his own behalf or on behalf of the natural or
legal person or entity he represents.’ Practice shows
that when a competent person prescribes a
prescription, separate authorization is not necessary. If
a person that is not authorized draws up the
prescription, separate authorization is necessary. The
doctor must know the drawer of the prescription
(usually a nurse). The software system provides this
information; the authorizing doctor can see who filed
the prescription, and at what time, for the purpose of
authorization. One question is whether an electronic
signature by means of a username and password is
sufficiently reliable as the law requires. Even though the
use of a username and password is a common method,
it cannot be regarded as sufficiently reliable taken the
purpose of the signature – distributing medication – into
consideration. The distribution of medication should be
5 Wet van 12 mei 1928, tot vaststelling van
bepalingen betreffende het opium en andere
verdoovende middelen,
http://wetten.overheid.nl/cgi-
bin/deeplink/law1/title=Opiumwet (Dutch only).
6 Besluit voorschrijven Opiumwet-middelen,
http://wetten.overheid.nl/cgi-
bin/deeplink/law1/title=Besluit%20voorschrijven
%20Opiumwet-middelen (Dutch only).
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handled with care and should remain confidential, since
it is part of the medical data of the patient. The
consequences of the prescription, and in this case the
complete medication order, are far-reaching and should
therefore be considerably secured to prevent problems.
This is particularly important when taking into account
the stringent rules from the Opium Act. It cannot be
assumed that the use of a username and password is
sufficient to protect and authorize prescriptions. Sad
but true, most people still use the name of their loved
one, a pet, their street name, postal code or birthday as
a password.7 Such a ‘safety’ measure will not improve
the security of the medication distribution, since
usernames and passwords are easily hacked even
though a hospital seems like a secure environment. The
request for medication is over wi-fi within the confines
of an intranet, and it is anticipated in the design of the
system that doctors will be able to provide
authorization from their office at home, viewing the
medical data on-line. In the case where the prescriber
automatically authorizes the prescription by the mere
fact that he or she is logged on to the system, it is
essential to protect the system from infringement. If the
current Opium Law can allow the use of electronic
signatures, a high degree of protection of the system
ought to be one of the first requirements. As stated
earlier, the EU Directive regards an electronic signature
as legally equal to a handwritten signature on paper as
long as a qualified certificate is present. Without a
qualified certificate, it is possible to argue that a
hospital does not act completely in accordance with the
law, unless there agreements between parties (hospital
and doctors) exist in order to guarantee the legal force
of the electronic signature.
In practice, a colleague, rather than the doctor,
authorizes prescriptions. With one touch of a button, a
doctor can authorize all distribution requests for the
patient on the department he is authorized for. This
means the doctor can authorize medicines for his
patients that are not prescribed by him. It would not be
practical to restrict this, but it is legally unthinkable,
because the electronic signature longer corresponds to
the requirements of the RURg. However, this practice is
not illegal, because every doctor is competent to
authorize and prescribe medication. In addition, if a
doctor authorizes the prescriptions of others, it will be
harder to find out which doctor is the true prescriber,
because the electronic signature is from somebody else.
Questions from the pharmacist on quantities,
indistinctness (such as contrast with allergies) or
requests to change the type of medication are then
complicated. The solution for this problem lies within
the system itself. It is programmed in such a way that all
entries are logged by user and competency, and
providing people do not start to share usernames and
passwords, the pharmacist can easily determine the
person responsible for prescribing the medication.
Trusted Third Parties as a solution 
With the development of PKI-Government (Public Key
Infrastructure), reliable electronic communication within
and with the Dutch government is provided. The Central
Agency for Information on Healthcare Professional
(CIBG) is one of the TTPs that joined the PKI-
government and meets the requirements of certificate-
holders from the EU Directive. The TTP is organised in
the Dutch Unique Healthcare Provider Identification
Register (UZI-register), which takes care of the
provisions of certificates in the healthcare sector. The
UZI-Register provides an electronic passport (an UZI-
card) with a PIN code to permit health care providers to
authenticate and identify the sender, which guarantees
the confidentiality of the data through encryption and
by entering digital signatures.
The card can be used if the EPM is designed to handle
cards and if a card reader is provided. The qualified
certificate offers a solution to the problem of
authorization in medication distribution. A recognisable
certificate improves the reliability of the electronic
communication and provides clarity for prescriber and
pharmacist. Even though the hospital I based my
research on is not working with a certificate yet, they
recognise the necessity to do so and the system is
equipped with the necessary applications. It is
recommended to make sure the qualified certificate is
provided as soon as possible to meet the legal
standards. Hospitals are following the government’s
solution to use a TTP for security.
Accepting electronic authorization
Doctors are, in some cases, and for several reasons, not
prepared to sign their prescriptions electronically. The
refusal to do so can be related to a lack of knowledge
and trust about the digital systems, or doctors are just
not prepared to authorize their prescription
electronically.8 Such a refusal leads to problems,
7 Conference privacy in healthcare (Privacy in de
gezondheidszorg, Dutch only) organised by the
Regional Privacy Committee for Healthcare, June
9th 2006, presentation by Getronics/PinkRoccade
on information safety.
8 These few examples of rejecting electronic
authorization are found in the Dutch hospital at
which the author is conducting her research.
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because the pharmacy is no longer equipped to process
paper prescriptions, and has made a conscious choice
to work with digital prescription in the interests of
efficiency and medication security. As previously
mentioned, the pharmacy is legally obliged not to
distribute medication if a description lacks a signature.
Refusal to sign means that medicines cannot be
distributed and the doctor cannot perform his tasks. In
practice though, distribution often occurs without a
written signature, but with an oral confirmation of the
medication ordered. This is in contrast with the legal
requirements. This has consequences for the
pharmacist (who is obliged to distribute medication
only if the prescription is sufficiently authorized), and
for the possible liability of the doctor. Liability for the
act of prescribing medicines is easy to deny if no proof
of prescription exists. Without a signature, no one
knows if the doctor in question truly prescribed the
medicine.
Accepting paper prescriptions is also not advisable.
Even though it is not legally forbidden to accept
(handwritten) paper prescriptions as long as they are
sufficiently authorized, it does lead to a unstable
system. It might even lead to a disturbance in the
introduction of electronic systems, since the explicit
need for these systems will not be recognised.
Especially if the choice is finally made to digitalise, one
should make sure that the whole system becomes
digital. The EPM is not (and should not) even be
designed to process paper prescriptions, since they
need to be manually fed into the system and all
signatures have to be scanned in order to comply with
the law. The existence of two systems, one digital and
one analogue, will not lead to the desired effect of more
security in medication distribution.
It is not unthinkable that the reason to refuse to sign
electronically is founded in the fear for a compromised
system.9 It is therefore necessary to create awareness
among prescribers that the system is sufficiently secure
which might lead to a different perspective on electronic
prescription systems. New government initiatives such
as the Medication Dossier will finally force physicians to
accept new technological developments in healthcare.
The future
In the bill10 for a new Law on medication, the
explanatory statement takes the first step in the right
direction for the acceptation of electronic signatures on
prescriptions or medication orders:
“first of all the word «document» is introduced. This
term does not only refer to the traditional piece of
paper signed by the prescriber including information
on his identity, the patient’s identity and the required
medicine, but also refers to other data carriers such
as electronically drawn and sent documents. Other
data carries than the traditional paper prescription
requires such a protection that the prescriber sending
the data can be recognised by the intended recipient
(the pharmacy) based on the agreements made
between parties. This requirement replaces the
requirement that the prescription should always be
signed by the prescriber.”11
Such a new requirement can immediately solve the
problems surrounding the identity of the authorizer for
the healthcare provider if the healthcare provider takes
care of sufficient protection in the dispatch and uses a
TTP. This bill might also lead to the earlier recommend
change in the Opium Law, to equally set the standards
on the authorization of prescriptions. Such a change
makes it easier for hospitals to implement an Electronic
Prescription of Medication system. A problem that will
not be solved implementing TTPs, changing laws or
acceptance by doctors, is the complicated and costly
implementation of advanced electronic signatures and
their protection. Taking all the problems into
consideration and weighing the advantages, it is
possible to conclude that the provision of electronic
means for healthcare providers can help to protect
medication distribution and improve efficiency.
© Simone van Esch, 2006
9 There is no evidence to substantiate this point. It
is the conclusion reached by the author as a result
of observations made in the hospital in which the
research is being conducted.
10 Geneesmiddelenwet 2006, not yet in force,
accepted by the parliament in April 2006, the
Senate will start their procedure for preliminary
investigation as of September 2006.
11 Tweede Kamer, vergaderjaar 2003–2004, 29 359,
nr. 3 29; p. 29-30 (Dutch only)
http://www.nvilg.nl/uploads/Geneesmiddelenwet-
mrt2004.pdf.
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